Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 398,080 | 417,935 | 309,816 | 166,076 | 138,509 |
| Cost of Goods | 50,649 | 63,385 | 31,960 | 16,860 | 12,307 |
| Gross Profit | 347,431 | 354,550 | 277,856 | 149,216 | 126,202 |
| Operating Expenses | 362,410 | 408,639 | 348,842 | 321,240 | 298,494 |
| Operating Income | -14,330 | -53,704 | -70,026 | -171,164 | -171,985 |
| Interest Expense | 20,698 | 20,654 | 21,134 | 21,111 | 21,307 |
| Other Income | 4,411 | -1,690 | -1,326 | 1,414 | -5,113 |
| Pre-tax Income | -30,617 | -76,048 | -92,486 | -190,861 | -198,405 |
| Income Tax | 5,485 | -1,379 | 1,330 | 30,131 | 299 |
| Net Income Continuous | -36,102 | -74,669 | -93,816 | -220,992 | -198,704 |
| Minority Interests | 5,529 | -938 | 1,333 | -32,144 | -98 |
| Net Income | $-41,631 | $-73,731 | $-95,149 | $-188,848 | $-198,606 |
| EPS Basic Total Ops | -0.17 | -0.31 | -0.39 | -0.78 | -0.83 |
| EPS Basic Continuous Ops | -0.15 | -0.30 | -0.39 | -0.92 | -0.83 |
| EPS Diluted Total Ops | -0.17 | -0.31 | -0.39 | -0.78 | -0.83 |
| EPS Diluted Continuous Ops | -0.15 | -0.30 | -0.39 | -0.92 | -0.83 |
| EBITDA(a) | $2,085 | $-37,957 | $-53,858 | $-157,099 | $-155,622 |